Other research pointed out that the cholesterol dysmetabolism prompted by APOE4 might mediate Alzheimer’s disease-associated pathologies (Huang et al., 2022; Jeong et al., 2019). This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.